144 related articles for article (PubMed ID: 37830952)
1. Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19.
Rice E; Oakes DB; Holland C; Moore HC; Blyth CC
Curr Opin Infect Dis; 2023 Dec; 36(6):522-528. PubMed ID: 37830952
[TBL] [Abstract][Full Text] [Related]
2. RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future.
Stein RT; Zar HJ
Pediatr Pulmonol; 2023 Jun; 58(6):1631-1639. PubMed ID: 36811330
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus infection in the modern era.
Ludlow M
Curr Opin Infect Dis; 2023 Jun; 36(3):155-163. PubMed ID: 36939556
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions.
Binns E; Tuckerman J; Licciardi PV; Wurzel D
J Paediatr Child Health; 2022 Oct; 58(10):1741-1746. PubMed ID: 36073299
[TBL] [Abstract][Full Text] [Related]
5. Evolving Epidemiology of Pediatric Respiratory Syncytial Virus (RSV) Cases Around COVID-19 Pandemic: Impact and Clinical Insights, Retrospective Cohort Study.
Gashgarey D; Alsuhaibani M; Alhuthil R; Alhabshan H; Alabdulqader A; Badran R; Balhmar A; Aldawood H; AlBanyan EA; AlGhamdi S; AlJumaah S; AlYabes O; Al-Hajjar S
J Epidemiol Glob Health; 2024 Jun; 14(2):319-326. PubMed ID: 38573464
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.
Holmdahl I; Bents SJ; Baker RE; Casalegno JS; Trovão NS; Park SW; Metcalf JE; Viboud C; Grenfell B
Sci Rep; 2024 Jun; 14(1):14527. PubMed ID: 38914626
[TBL] [Abstract][Full Text] [Related]
8. Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.
Leija-Martínez JJ; Esparza-Miranda LA; Rivera-Alfaro G; Noyola DE
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543794
[TBL] [Abstract][Full Text] [Related]
9. Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
Jiang ML; Xu YP; Wu H; Zhu RN; Sun Y; Chen DM; Wang F; Zhou YT; Guo Q; Wu A; Qian Y; Zhou HY; Zhao LQ
J Med Virol; 2023 Jan; 95(1):e28411. PubMed ID: 36524893
[TBL] [Abstract][Full Text] [Related]
10. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
Li Y; Wang X; Blau DM; Caballero MT; Feikin DR; Gill CJ; Madhi SA; Omer SB; Simões EAF; Campbell H; Pariente AB; Bardach D; Bassat Q; Casalegno JS; Chakhunashvili G; Crawford N; Danilenko D; Do LAH; Echavarria M; Gentile A; Gordon A; Heikkinen T; Huang QS; Jullien S; Krishnan A; Lopez EL; Markić J; Mira-Iglesias A; Moore HC; Moyes J; Mwananyanda L; Nokes DJ; Noordeen F; Obodai E; Palani N; Romero C; Salimi V; Satav A; Seo E; Shchomak Z; Singleton R; Stolyarov K; Stoszek SK; von Gottberg A; Wurzel D; Yoshida LM; Yung CF; Zar HJ; ; Nair H;
Lancet; 2022 May; 399(10340):2047-2064. PubMed ID: 35598608
[TBL] [Abstract][Full Text] [Related]
11. Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program.
Vianna LA; Siqueira MM; Volpini LPB; Louro ID; Resende PC
PLoS One; 2021; 16(5):e0251361. PubMed ID: 34003843
[TBL] [Abstract][Full Text] [Related]
12. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France.
Fourgeaud J; Toubiana J; Chappuy H; Delacourt C; Moulin F; Parize P; Scemla A; Abid H; Leruez-Ville M; Frange P
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2389-2395. PubMed ID: 34347190
[TBL] [Abstract][Full Text] [Related]
13. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa.
Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE
Influenza Other Respir Viruses; 2023 Dec; 17(12):e13229. PubMed ID: 38090227
[TBL] [Abstract][Full Text] [Related]
14. Global molecular diversity of RSV - the "INFORM RSV" study.
Langedijk AC; Lebbink RJ; Naaktgeboren C; Evers A; Viveen MC; Greenough A; Heikkinen T; Stein RT; Richmond P; Martinón-Torres F; Nunes M; Hosoya M; Keller C; Bauck M; Cohen R; Papenburg J; Pernica J; Hennus MP; Jin H; Tabor DE; Tovchigrechko A; Ruzin A; Abram ME; Wilkins D; Wildenbeest JG; Kragten-Tabatabaie L; Coenjaerts FEJ; Esser MT; Bont LJ
BMC Infect Dis; 2020 Jun; 20(1):450. PubMed ID: 32591017
[TBL] [Abstract][Full Text] [Related]
15. Time trend and seasonality in medically attended respiratory syncytial virus (RSV) infections in US children aged 0-5 years, January 2010-January 2023.
Wang L; Berger N; Davis PB; Kaelber DC; Volkow N; Xu R
Fam Med Community Health; 2023 Oct; 11(4):. PubMed ID: 37844966
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
Ravkin HD; Yom-Tov E; Nesher L
J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
[TBL] [Abstract][Full Text] [Related]
17. Changes following the Onset of the COVID-19 Pandemic in the Burden of Hospitalization for Respiratory Syncytial Virus Acute Lower Respiratory Infection in Children under Two Years: A Retrospective Study from Croatia.
Mrcela D; Markic J; Zhao C; Viskovic DV; Milic P; Copac R; Li Y
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560751
[TBL] [Abstract][Full Text] [Related]
18. A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
Mohebi L; Karami H; Mirsalehi N; Ardestani NH; Yavarian J; Mard-Soltani M; Mokhatri-Azad T; Salimi V
J Med Virol; 2022 Dec; 94(12):5802-5807. PubMed ID: 35961780
[TBL] [Abstract][Full Text] [Related]
19. Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance.
Chadha M; Hirve S; Bancej C; Barr I; Baumeister E; Caetano B; Chittaganpitch M; Darmaa B; Ellis J; Fasce R; Kadjo H; Jackson S; Leung V; Pisareva M; Moyes J; Naguib A; Tivane A; Zhang W;
Influenza Other Respir Viruses; 2020 Nov; 14(6):638-646. PubMed ID: 32163226
[TBL] [Abstract][Full Text] [Related]
20. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures.
Billard MN; van de Ven PM; Baraldi B; Kragten-Tabatabaie L; Bont LJ; Wildenbeest JG
Influenza Other Respir Viruses; 2022 Sep; 16(5):926-936. PubMed ID: 35733362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
